COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177. doi: 10.1111/bcp.14335. Epub 2020 May 7.
No abstract available

Keywords: COVID-19; QT prolongation; azithromycin; hydroxychloroquine.

Publication types

  • Letter

MeSH terms

  • Azithromycin / administration & dosage*
  • Azithromycin / adverse effects
  • COVID-19
  • Chloroquine / administration & dosage*
  • Chloroquine / adverse effects
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Drug Therapy, Combination
  • Humans
  • Hydroxychloroquine / administration & dosage*
  • Hydroxychloroquine / adverse effects
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / epidemiology
  • Mental Disorders / complications
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Risk Factors

Substances

  • Hydroxychloroquine
  • Azithromycin
  • Chloroquine